logo
Whatever Happened To The Affordable New Car?

Whatever Happened To The Affordable New Car?

Forbesa day ago
New vehicle prices are showing no end to their meteoric rise, with the average manufacturer's suggested retail price (MSRP) now standing at over $51,000, according to Kelley Blue Book. That represents a 2.3% boost over the past year and is well over $10,000 more than the average car cost in 2020. And there's still no telling how much new-vehicle prices will increase moving forward with President Trump's tariffs being levied on imported cars, steel and components.
Aside from inflation and changing market forces, today's stratospheric new-vehicle prices can be attributed to how they're being equipped. The days are long gone since an 'economy car' meant one that came with manual locks, roll-up windows and just an AM/FM radio. Today it's tough to find a given model on a dealer's lot that isn't loaded with profit-padding perks that were until only recently limited to top-shelf luxury cars.
With the Kia Rio and Mitsubishi Mirage having left the U.S. market the number of cars that start at less than $20,000 is down to just one, the Nissan Versa at $17,190, though one would be hard-pressed to find a base model with a manual transmission in a given dealer's inventory.
What's more, Cars Commerce reports that the number of new vehicles selling for under $30,000 is now down to 13.6% of the market as compared to 38% in pre-pandemic 2019. And since 92% of the lowest-stickered vehicles are imported, there's likely to be even fewer sub-$30,000 models up for grabs in a tariff-tempered economy.
If the Future Attribute Demand Study (FADS) conducted by the research firm AutoPacific is any indication, automakers may need to return to the days of basic transportation by building more models and trims that eschew some flashier new-vehicle features for the sake of maintaining more-reasonable MSRPs.
The company surveyed over 14,000 new vehicle intenders to gauge their interest in more than 160 current automotive features and found that shoppers looking to spend no more than $35,000 on a new vehicle are less likely to demand widely offered upscale features than more affluent buyers.
'Front wheel drive, base stereos, cloth seats with various manual adjustment, and analog gauges are 'in,' for these more frugal shoppers,' says Robby DeGraff, AutoPacific's manager of product and consumer insights, 'so the array of standard equipment found on entry- and mid-level trims of today's popular vehicles within the $25,000 to $35,000 price range may need to be reexamined as consumers tighten their belts in the face of economic uncertainty.'
The study determined that more price-conscious consumers remain open to consider a conventionally powered sedan that sticks close to the basics, with cloth upholstery, manual seat adjustments, an analog gauge cluster and easy-to-use physical buttons and dials. They say they can do without navigation, elaborate interactive displays and nearly-autonomous driving features. Those who can afford more than $35,000 say they favor more-fanciful amenities like driver profile settings, a household 110v outlet, and rear-window sunshades.
On the other hand, shoppers in both price ranges said they items like want wireless charging pads, heated and ventilated front seats and potentially life-saving active safety features like automatic emergency front and rear braking and lane- change assist. The least sought-after features among both groups include premium-branded audio systems, head-up displays and subscription-based immersive services.
While market demands may trigger a renaissance of more basically-equipped new cars, trucks and SUVs for the sake of cash-strapped buyers, don't expect to see crank-up windows, front bench seats, cigarette lighters or steering-column shifters returning to the market any time soon.
In the meantime, here's a list of the new cars and SUVs for 2025 that can still be found starting for less than $25,000, not including the destination charge, taxes, fees and options:
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Nutrien Declares Quarterly Dividend of US$0.545 per Share
Nutrien Declares Quarterly Dividend of US$0.545 per Share

Yahoo

time22 minutes ago

  • Yahoo

Nutrien Declares Quarterly Dividend of US$0.545 per Share

SASKATOON, Saskatchewan, August 06, 2025--(BUSINESS WIRE)--Nutrien Ltd. (TSX and NYSE: NTR) announced today that its Board of Directors has declared a quarterly dividend of US$0.545 per share payable on October 17, 2025, to shareholders of record on September 29, 2025. Registered shareholders who are residents of Canada as reflected in Nutrien's shareholders register, as well as beneficial holders (i.e., shareholders who hold their common shares through a broker or other intermediary) whose intermediary is a participant in CDS Clearing and Depositary Services Inc. or its nominee, CDS & Co., will receive their dividend in Canadian dollars, calculated based on the Bank of Canada daily average exchange rate on September 29, 2025. Registered shareholders resident outside of Canada as reflected in Nutrien's shareholders register, including the United States, as well as beneficial holders whose intermediary is a participant in The Depository Trust Company or its nominee, Cede & Co., will receive their dividend in US dollars. However, registered shareholders of Nutrien may elect to change the currency of their dividend payments to US dollars or Canadian dollars, as applicable. In addition, Nutrien offers registered shareholders direct deposit by electronic funds transfer for dividend payments. Registered shareholders may elect to change the currency of their dividend and enroll for direct deposit by contacting, Nutrien's registrar and transfer agent, Computershare Investor Services Inc., directly (1-800-564-6253 or service@ Beneficial shareholders should contact their broker or other intermediary to determine the ability and necessary steps involved in an election to change the currency of their dividend payment. For further details, please visit All dividends paid by Nutrien are, pursuant to subsection 89(14) of the Income Tax Act (Canada), designated as eligible dividends. About Nutrien Nutrien is a leading global provider of crop inputs and services. We operate a world-class network of production, distribution and ag retail facilities that positions us to efficiently serve the needs of growers. We focus on creating long-term value by prioritizing investments that strengthen the advantages of our business across the ag value chain and by maintaining access to the resources and the relationships with stakeholders needed to achieve our goals. View source version on Contacts Jeff HolzmanSenior Vice President, Investor Relations and FP&A(306) 933-8545Contact us at: Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Firefly Aerospace to price US IPO as it sets sights on a positive liftoff
Firefly Aerospace to price US IPO as it sets sights on a positive liftoff

Yahoo

time22 minutes ago

  • Yahoo

Firefly Aerospace to price US IPO as it sets sights on a positive liftoff

By Pritam Biswas and Arasu Kannagi Basil (Reuters) -Northrop Grumman-backed Firefly Aerospace, the buzzy space technology startup that put a lander on the moon, is set to price its U.S. IPO later on Wednesday. In a nascent but rapidly growing commercial space industry, Firefly's IPO has attracted investor attention because it successfully landed its uncrewed Blue Ghost spacecraft on the moon in its first attempt in March. Cedar Park, Texas-based Firefly Aerospace is set to sell 16.2 million shares of its stock, priced between $41 and $43 apiece. This range was raised earlier this week, signaling strong demand. U.S. President Donald Trump's focus on commercializing space technology and safeguarding the national interests in space has attracted venture capital firms and billionaires. Elon Musk's SpaceX — the most valuable private company in the world — has become a critical part of the U.S. satellite network, even prompting a need across the government to look for more contractors. The U.S. government is betting that diversifying its contractor base will foster innovation and cut the huge costs of sending rockets to space, as well as reduce over-reliance on a single provider for critical missions. NASA's procurement process now includes new entrants such as Firefly Aerospace and Sierra Space, alongside legacy companies, leveraging commercial partnerships for lunar landers, space station modules and cargo deliveries. While space-related IPOs have been scarce in recent years, the tide is starting to turn in 2025. Firefly's listing comes on the heels of the successful New York flotations of space and defense firms Karman, AIRO Group and Voyager. As of Tuesday's close, shares of Karman have more than doubled from their offer price, while Voyager has gained 10%. "Given Firefly and the success of Voyager, I think you are going to see several more space-related companies test the waters of a public offering," said Ross Carmel, partner at law firm Sichenzia Ross Ference Carmel. TO THE MOON Formed in 2017, Firefly designs and manufactures small- to medium-lift launch vehicles, lunar landers and orbital vehicles. It had a backlog of roughly $1.1 billion and over 30 planned launches under contract as of March 31. While Houston-based Intuitive Machines' Odysseus lander was the first private lander to reach the moon last year, it made a lopsided touchdown, landing mostly intact but dooming many of its onboard instruments. Firefly's was the second, but its Blue Ghost spacecraft landed safely, reaching the moon's surface a month and a half after launching atop a SpaceX rocket from NASA's Kennedy Space Center in Florida. Last month, Firefly secured a $176.7 million contract to deliver five NASA payloads to the Moon's South Pole in 2029. Firefly was valued at more than $2 billion in a 2024 funding round. The company's backers include aerospace-focused private investment firm AE Industrial Partners. U.S. defense contractor Northrop Grumman, which invested $50 million into Firefly to aid the production of their jointly developed rocket, is one of three suppliers of solid rocket motors (SRMs) to the United States. Firefly is expected to begin trading on the Nasdaq under the ticker symbol "FLY" on Thursday.

Novo Nordisk Ramps Up U.S. Legal Fight Over Wegovy, Ozempic Copies
Novo Nordisk Ramps Up U.S. Legal Fight Over Wegovy, Ozempic Copies

Yahoo

time22 minutes ago

  • Yahoo

Novo Nordisk Ramps Up U.S. Legal Fight Over Wegovy, Ozempic Copies

Novo Nordisk (NOVO, Financials) expanded its U.S. legal campaign against makers of unapproved versions of semaglutide the active ingredient in its blockbuster weight?loss and diabetes drugs Wegovy and Ozempic. The Danish drugmaker said Tuesday it filed 14 new lawsuits; the targets include telehealth providers, compounding pharmacies, and medical spas accused of selling compounded semaglutide under the fake guise of personalization. Warning! GuruFocus has detected 1 Warning Sign with NVO. The suits name firms such as Prism Aesthetics, Mochi Health, and Fella Health; some have also appeared in Eli Lilly's (LLY, Financials) litigation over knockoff versions of its weight?loss drug Zepbound. Novo claims the defendants are steering patients toward compounded semaglutide that has not been approved by regulators; in some cases, the products allegedly contain illicit foreign?sourced active pharmaceutical ingredients. Compounders were temporarily allowed to produce semaglutide during a declared shortage; when the U.S. Food and Drug Administration ended that allowance, some companies shifted to offering personalized versions outside the approved drug label. Novo argues the approach violates state laws on corporate practice of medicine; it also raises safety concerns, as the copies have not been proven effective. Industry groups pushed back; Scott Brunner, CEO of the Alliance for Pharmacy Compounding, said Novo's claims misrepresent the work of legitimate, state?licensed pharmacies. This article first appeared on GuruFocus. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store